DLH Holdings Corp. (DLHC) - 10-Q Summary
Business Context and Reporting Period
Company: DLH Holdings Corp.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended March 31, 2026
Business Overview: DLH provides technology-enabled business process outsourcing, program management, and public health research/analytics primarily to U.S. government agencies (HHS, VA, DoD). The company operates as a non-accelerated filer and smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Mar 31, 2026 | 6 Months Ended Mar 31, 2026 | 6 Months Ended Mar 31, 2025 |
|---|---|---|---|
| Revenue | $59,265 | $128,158 | $179,994 |
| Net Income (Loss) | $(2,535) | $(3,859) | $1,992 |
| Operating Income (Loss) | $(55) | $1,382 | $10,752 |
| EBITDA (Non-GAAP) | $4,245 | $9,982 | $19,324 |
| Adjusted EBITDA (Non-GAAP) | $5,327 | $11,872 | $19,324 |
| Cash and Equivalents | $131 | $131 | $196 |
| Total Debt (Net) | $129,961 | $129,961 | $128,033 |
| Operating Cash Flow | N/A | $(984) | $2,965 |
Liquidity: Cash balance is $131,000. Available borrowing capacity under the revolving credit facility is $9.7 million (net of letters of credit).
Debt Structure: Secured term loan of $122.0 million and revolving line of credit balance of $10.7 million. All debt is currently subject to floating interest rates (SOFR + 4.1%) following the maturity of an interest rate swap in January 2026.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 33.6% year-over-year for the six months ended March 31, 2026 ($51.8 million decrease). This is primarily attributed to the conversion of certain contracts to small business contractors (SDVOSB), specifically within the Department of Veterans Affairs (VA) CMOP program.
- Profitability Shift: The company reported a net loss of $3.9 million for the six months ended March 31, 2026, compared to net income of $2.0 million in the prior year period. Operating income dropped from $10.8 million to $1.4 million.
- Cost Structure: Contract costs decreased $41.5 million, aligning with the revenue decline. General and administrative (G&A) costs decreased $1.0 million but increased as a percentage of revenue (11.9% vs 9.1%) due to the lower revenue base. Management implemented cost scaling initiatives to align G&A with current volume.
- Cash Flow: Operating cash flow turned negative at $(1.0) million for the six-month period, compared to positive $3.0 million in the prior year, driven by the reduction in revenue volume.
Outlook, Risks, and Management Commentary
- Contract Transitions: The company is actively transitioning VA CMOP sites to SDVOSB prime contractors. One site transitioned in February 2026, with two others expected to transition in April and May 2026. This transition is the primary driver of current revenue headwinds.
- Backlog: Total backlog stands at $442.4 million, with $75.0 million funded, down from $514.3 million total backlog at the end of the prior fiscal year.
- Goodwill Impairment: A triggering event occurred due to a decline in share price and market capitalization. Management performed quantitative assessments (market and income-based methods) and concluded that goodwill is not impaired as fair value exceeds book value.
- Government Budget Risks: Management notes uncertainty regarding federal spending priorities, potential impacts of the "Department of Government Efficiency" (DOGE) initiatives, and ongoing funding instability for the Department of Homeland Security (though minimal revenue is derived from DHS).
- Interest Rate Risk: With the interest rate swap matured, all debt is floating. A 1.0% increase in SOFR would increase annual interest expense by approximately $1.3 million.
Investor Verification Checklist
- Contract Renewals: Verify the status of the remaining VA CMOP site transitions and the company's ability to secure subcontractor roles or new prime contracts to replace lost revenue.
- Liquidity Position: Monitor the $9.7 million remaining revolver capacity against the $132.7 million in debt obligations due within the next 12 months (including term loan amortization).
- Cost Scaling Effectiveness: Assess whether the reduction in G&A costs is sustainable and sufficient to maintain margins as revenue stabilizes.
- Goodwill Valuation: Review future quarterly reports for any further declines in market capitalization that could trigger additional impairment testing.
- Interest Rate Exposure: Evaluate the impact of potential SOFR increases on net income given the fully floating debt structure.